 This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis UC who have not responded at the end of the induction period in Study M14-234 Substudies 1 and 2, who have had loss of response during the maintenance period of Study M14-234 Substudy 3, or who have successfully completed Study M14-234. 